Cas no 129541-43-1 (5-Bromo-4-chloro-1H-indol-3-yl Butanoate)
5-Bromo-4-chloro-1H-indol-3-yl Butanoate Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-4-chloro-1H-indol-3-yl butyrate
- (5-bromo-4-chloro-1H-indol-3-yl)butanoate
- 5-BROMO-4-CHLORO-(1H-INDOL-3-YL) BUTANOATE
- 5-BroMo-4-chloro-3-indolyl butyrate
- 5-Bromo-4-chloro-3-indoxyl butyrate
- Bacteria chromogenic substrate-1
- Butanoic acid,5-bromo-4-chloro-1H-indol-3-yl ester
- X-BUTYRATE
- 5-BROMO-4-CHLOROINDOXYLBUTYRATE
- 5-Bromo-4-chloro-(1H-indol-3-yl) butyrate
- 5-Bromo-4-chloro-3-indoxyl butyrateX-Butyrate
- Butanoic acid, 5-broMo-4-chloro-1H-indol-3-yl ester
- 5-Bromo-4-chloro-3-indolyl butyrate, >=99%
- SCHEMBL1614924
- (5-bromo-4-chloro-1H-indol-3-yl) butanoate
- FT-0620121
- AS-68946
- 5-bromo-4-chloro-1H-indol-3-yl butanoate
- DTXSID00350895
- B-7050
- HY-78639
- 129541-43-1
- A888844
- H10237
- CS-M2349
- AMY41486
- MFCD00083261
- AKOS022180540
- PD078545
- 5-Bromo-4-chloro-1H-indol-3-yl Butanoate
-
- MDL: MFCD00083261
- Inchi: 1S/C12H11BrClNO2/c1-2-3-10(16)17-9-6-15-8-5-4-7(13)12(14)11(8)9/h4-6,15H,2-3H2,1H3
- InChI Key: UKTKOBRRRRODGL-UHFFFAOYSA-N
- SMILES: BrC1C=CC2=C(C=1Cl)C(=CN2)OC(CCC)=O
Computed Properties
- Exact Mass: 314.96600
- Monoisotopic Mass: 314.96617g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 17
- Rotatable Bond Count: 4
- Complexity: 290
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 3.9
- Topological Polar Surface Area: 42.1?2
Experimental Properties
- Color/Form: White powder
- Melting Point: 91-93 °C
- PSA: 42.09000
- LogP: 4.28930
- Solubility: Insoluble in water
5-Bromo-4-chloro-1H-indol-3-yl Butanoate Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Bromo-4-chloro-1H-indol-3-yl Butanoate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | B9151-5MG |
5-Bromo-4-chloro-3-indolyl butyrate |
129541-43-1 | 5mg |
¥1555.24 | 2023-09-28 | ||
| Alichem | A199008915-1g |
5-Bromo-4-chloro-1H-indol-3-yl butyrate |
129541-43-1 | 97% | 1g |
$555.39 | 2022-04-03 | |
| Alichem | A199008915-5g |
5-Bromo-4-chloro-1H-indol-3-yl butyrate |
129541-43-1 | 97% | 5g |
$2,166.48 | 2022-04-03 | |
| TRC | B701055-5mg |
5-Bromo-4-chloro-1H-indol-3-yl Butanoate |
129541-43-1 | 5mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B701055-50mg |
5-Bromo-4-chloro-1H-indol-3-yl Butanoate |
129541-43-1 | 50mg |
$ 98.00 | 2023-04-18 | ||
| TRC | B701055-100mg |
5-Bromo-4-chloro-1H-indol-3-yl Butanoate |
129541-43-1 | 100mg |
$ 138.00 | 2023-04-18 | ||
| TRC | B701055-500mg |
5-Bromo-4-chloro-1H-indol-3-yl Butanoate |
129541-43-1 | 500mg |
$ 563.00 | 2023-04-18 | ||
| Chemenu | CM232706-1g |
5-Bromo-4-chloro-1H-indol-3-yl butyrate |
129541-43-1 | 95%+ | 1g |
$525 | 2021-08-04 | |
| Chemenu | CM232706-5g |
5-Bromo-4-chloro-1H-indol-3-yl butyrate |
129541-43-1 | 95%+ | 5g |
$1986 | 2021-08-04 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B855463-250mg |
5-Bromo-4-chloro-3-indolyl butyrate |
129541-43-1 | 99% | 250mg |
6,084.00 | 2021-05-17 |
5-Bromo-4-chloro-1H-indol-3-yl Butanoate Suppliers
5-Bromo-4-chloro-1H-indol-3-yl Butanoate Related Literature
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
Additional information on 5-Bromo-4-chloro-1H-indol-3-yl Butanoate
Comprehensive Overview of 5-Bromo-4-chloro-1H-indol-3-yl Butanoate (CAS No. 129541-43-1)
5-Bromo-4-chloro-1H-indol-3-yl Butanoate (CAS No. 129541-43-1) is a synthetic indole derivative that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique bromo and chloro substitutions on the indole ring, serves as a versatile intermediate in the synthesis of bioactive molecules. Researchers are particularly interested in its potential applications in drug discovery, owing to its structural similarity to naturally occurring indole alkaloids, which are known for their diverse biological activities.
The growing interest in 5-Bromo-4-chloro-1H-indol-3-yl Butanoate aligns with current trends in precision medicine and targeted therapy. As the scientific community explores novel ways to combat complex diseases, compounds like this are being investigated for their ability to modulate specific biochemical pathways. For instance, indole derivatives are frequently studied for their roles in enzyme inhibition and receptor binding, making them valuable tools in the development of new therapeutics.
One of the most frequently asked questions about 5-Bromo-4-chloro-1H-indol-3-yl Butanoate revolves around its synthetic methodology. Researchers often search for optimized protocols to produce this compound with high yield and purity. Recent advancements in green chemistry have also sparked interest in eco-friendly synthesis routes, minimizing hazardous byproducts and reducing environmental impact. This aligns with the broader industry shift toward sustainable chemistry practices.
Another hot topic is the compound's potential role in neuropharmacology. Indole derivatives are known to interact with serotonin receptors, which are critical in treating neurological disorders. While 5-Bromo-4-chloro-1H-indol-3-yl Butanoate itself is not a drug, its structural features make it a promising scaffold for designing central nervous system (CNS)-targeting molecules. This has led to increased demand from academic and industrial labs specializing in neurodegenerative disease research.
From a commercial perspective, the global market for specialized indole derivatives is expanding rapidly. 5-Bromo-4-chloro-1H-indol-3-yl Butanoate is often listed as a high-purity reference standard for analytical purposes, particularly in HPLC and LC-MS applications. Quality control in pharmaceutical manufacturing relies heavily on such compounds to ensure batch consistency and regulatory compliance.
In summary, 5-Bromo-4-chloro-1H-indol-3-yl Butanoate (CAS No. 129541-43-1) represents a fascinating intersection of medicinal chemistry and biochemical research. Its relevance to contemporary scientific challenges—from drug development to analytical chemistry—ensures its continued importance in modern laboratories. As research progresses, this compound may unlock new possibilities in therapeutic innovation and scientific discovery.
129541-43-1 (5-Bromo-4-chloro-1H-indol-3-yl Butanoate) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)